BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3022122)

  • 1. [Transfer of active oncogenes and promoters into the mouse cell genome].
    Tatosian AG; Topol' LZ; Ambartsumian NS
    Mol Biol (Mosk); 1986; 20(5):1226-35. PubMed ID: 3022122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transfection of a plasmid with a retrovirus promoter: distribution of sequences in the genome of induced tumors].
    Glazachev VA; Topol' LZ; Tatosian AG
    Mol Biol (Mosk); 1988; 22(2):506-16. PubMed ID: 2839768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation.
    Araujo JC; Doniger J; Stöppler H; Sadaie MR; Rosenthal LJ
    Oncogene; 1997 Feb; 14(8):937-43. PubMed ID: 9050993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of the transforming Ha-ras gene in human melanoma, neuroblastoma and breast cancer cells].
    Kniazev PG; Schäfer R; Willecke K; Seits IF
    Vopr Onkol; 1985; 31(6):77-85. PubMed ID: 4024551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line.
    Chang EH; Morgan PL; Lee EJ; Pirollo KF; White EA; Patrick DH; Tsichlis PN
    J Exp Pathol; 1985; 2(3):177-89. PubMed ID: 3842394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumorigenesis by transected cells in nude mice: a new method for detecting cellular transforming genes.
    Blair DG; Cooper CS; Oskarsson MK; Eader LA; Vande Woude GF
    Prog Clin Biol Res; 1983; 119():79-90. PubMed ID: 6346333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activation of ras and myc proto-oncogenes in human breast carcinoma and neuroblastoma].
    Kniazev PG; Schafer R; Willecke K; Pluzhnikova GF; Serova OM
    Mol Biol (Mosk); 1986; 20(5):1236-43. PubMed ID: 3022123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming potential and growth stimulating activity of the v-fos and c-fos genes carried by avian retrovirus vectors.
    Iba H; Shindo Y; Nishina H; Yoshida T
    Oncogene Res; 1988; 2(2):121-33. PubMed ID: 2851123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous transfer of tumorigenic and metastatic phenotypes by transfection with genomic DNA from a human cutaneous squamous cell carcinoma.
    Ananthaswamy HN; Price JE; Goldberg LH; Bales ES
    J Cell Biochem; 1988 Feb; 36(2):137-46. PubMed ID: 3356753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection and preliminary characteristics of the transforming gene (oncogene) of Ha-ras type in human stomach cancer].
    Kniazev PG; Schäfer R; Kalinovskiĭ VP; Matveev BV; Mel'nikov RA
    Mol Biol (Mosk); 1986; 20(6):1513-21. PubMed ID: 3027534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between Marek's disease virus encoded or induced factors and the Rous sarcoma virus long terminal repeat promoter.
    Banders UT; Coussens PM
    Virology; 1994 Feb; 199(1):1-10. PubMed ID: 8116231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the rous sarcoma virus long terminal repeat-driven transcription by in vitro methylation: different sensitivity in permissive chicken cells versus mammalian cells.
    Hejnar J; Plachý J; Geryk J; Machon O; Trejbalová K; Guntaka RV; Svoboda J
    Virology; 1999 Mar; 255(1):171-81. PubMed ID: 10049832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid rescue of an oncogenic sequence containing a mouse mammary tumor virus gene.
    Van Klaveren P; Haaksma T; Dijk H; Bentvelzen P
    Anticancer Res; 1994; 14(2A):597-601. PubMed ID: 7517122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
    Mukhtar M; Duan L; Bagasra O; Pomerantz RJ
    Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of proto-oncogenes in human lymphoid cells immortalized by transfection with extrachromosomal DNA of mouse L cells.
    Abken H; Bützler C; Willecke K
    Anticancer Res; 1990; 10(1):73-80. PubMed ID: 2334143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation of rodent immortalized and embryo cells by oncogenes. I. Mouse (NIH 3T3) and rat (FR 3T3) immortalized fibroblasts.
    Denner J; Ehm I; Jandrig B; Friese D
    Arch Geschwulstforsch; 1987; 57(6):463-74. PubMed ID: 3435225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective retrovirus insertion activates c-Ha-ras protooncogene in an MNU-induced rat mammary carcinoma.
    Bera TK; Tsukamoto T; Panda DK; Huang T; Guzman RC; Hwang SI; Nandi S
    Biochem Biophys Res Commun; 1998 Jul; 248(3):835-40. PubMed ID: 9704014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of proviral sequences in RSV-transformed mouse tumour cells accompanied by the formation of double-minute chromatin bodies.
    Sainerová H; Svoboda J
    Folia Biol (Praha); 1983; 29(6):403-11. PubMed ID: 6321249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal diversity of the Kirsten-ras oncogene during tumor progression in athymic nude mice: mechanisms of amplification and rearrangement.
    Radinsky R; Kraemer PM; Proffitt MR; Culp LA
    Cancer Res; 1988 Sep; 48(17):4941-53. PubMed ID: 3409227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.